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PRELIMINARY AND SHORT REPORT
ON THE MECHANISM OF MELANIN PIGMENTATION IN ENDOCHINE
DISORDEHS8t
AARON BUNSEN LEENER, M.D., PH.D., KAZUO SHIZUME, M.D., AND
THOMAS B. FITZPATRICK, M.D., Pn.D.
In this preliminary report it will be shown that the increased melanin pigmentation
associated with Addison's disease and pregnancy is probably dne to an iacreased output
of the melanocyte stimulating hormonet (MSH) from the pituitary gland. Other hormones,
and physical factors, also contribute to this hyperpigmentation. A detailed report, together
with a review of events leading to this interesting finding, will be published shortly.
Previously it was pointed out (1—4) that clinical evidence supports the view that hyper-
activity of the pituitary gland is associated with an increase in pigmentation whereas a
decrease in pituitary function results in decreased pigmentation. In addition, it has been
known for many years that pituitary extracts could cause darkening of frog and fish skin.
However, no correlation of these observations was considered because pituitary extracts
had not been shown to increase pigmentation in man. On the contrary, it was often re-
marked that the effect of pituitary extracts on frog skin had no hearing on the mechanism
of pigmentation in man. This early conclusion was based on the use of pituitary extracts
which contained only minute quantities of MSH. However, when adequate quantities of
MSH are injected into man, increase in pigmentation develops. In addition we have shown
that urinary excretion of MSH is increased during pregnancy and in Addison's disease (5).
MSH from hog pituitary glands was prepared for us by the Armour Laboratories. One
of the fractions tested had a potency of 1.0 x 108 units of MSH per mg. The amounts of
ACTH, vaSopressin, and oxytocin were very small, being 0.036 units per mg., 0.01 units per
mg., and less than 0.05 units per mg., respectively. This material was injected into three
human beings. One was a normal white male, another a white male with vitiligo, and the
third a Negress with vitiligo. All three individuals developed increased melanin pigmenta-
tion; in addition, new nevi possibly may have been produced in the normal male.
Cese 1. P. Y., a 41 year old normal white male, received 4.18 grams of MSH (4.18 x 108
units MSH) intramuscularly over a 36 day period. After the first two weeks increased pig-
mentation was observed over the entire skin surface, especially the face. This pigmentation
deepened in color throughout the experimental period. Pigmented nevi became darker,
and it is possible that new nevi were produced.
Cese 2. C. K., aSS year old white male with vitiligo of long duration, received 3.12 grams
of MSH (3.12 x 108 units MSH) over a 32 day period. No effect was observed in the vitiligi-
nous areas although the sites of normal pigmentation became much darker in color. Three
to four months after cessation of treatment the skin returned to its previous color.
Cese 3. P. C., a 29 year old Negro female with long standing vitiligo, received 4.50 grams
of MSH (4.50 x 108 units MSH) over a 50 day period. After two to three weeks she showed
increased pigmentation over most of the non-vitiliginous areas. This pigmentation became
very marked toward the end of the study. A small degree of perifollieular repigmentation
appeared in the vitiliginous areas. About 2j4 months after administration of MSH was dis-
continued, the pigmentation decreased to its previous state.
* From the Division of Dermatology, University of Oregon Medical School, Portland,
Oregon.
t This work was done in part under a Grant-in-Aid from the American Cancer Society
upon recommendation of the Committee on Growth of the National Research Council and
from the Sloan Foundation.
tIn the past, the terms intermedin, melanophore hormone, melanophore dilating prin-
ciple, etc. have been used to refer to the melanocyte stimulating hormone.
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Since urinary excretion of MSH is augmented during pregnancy and in Addison's disease,
and since injections of MSH will produce increased pigmentation in a normal man, it is
highly probable that the excess quantities of MSll are in large part responsible for the pig-
mentation found in these conditions. Other hormones, such as nor-adrenaline, adrenaline,
hydrocortisone, and progesterone also play either direct or indirect roles (4).
Nor-adrenaline and adrenaline inhibit the local action of MSH on the melanocytes;
hydrocortisone inhibits the release of MSH from the pituitary; and progesterone darkens
melanocytes through a direct MSH-like action. Hence in Addison's disease, in which there
is a decrease in hydrocortisone, there is an increase in MSH resulting in increased pigmenta-
tion. If in addition to hypofunction of the adrenal cortex there is nlso destruction or hypo-
function of the adrenal medulla, there will be a decrease in noradrenaline and adrenaline
with a consequent further increase in pigmentation because normal inhibitors of MSII are
not acting. In pregnancy the hyperpigmentation may be due to increased quantities of
MSH and progesterone because the latter seems to have a direct MSH-like effect on the
melanocytes.
CONCLUSION
It has been shown for the first time that injections of MSH can produce generalized
darkening of human skin as well as that of frogs. This hormone, which is distinct from
other pituitary hormones, is largely responsible for the pigmentation seen in Addison's
disease and pregnancy. Nor-adrenaline, adrenaline, hydrocortisone, and progesterone also
play a part.
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